Back
Intellia Therapeutics Stock Price Chart
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
37
NTLA
Intellia Therapeutics
Last Price:
$9.18
Seasonality Move:
19.08%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.74 | Buy |
| 20-day SMA: | 8.46 | Buy |
| 50-day SMA: | 8.18 | Buy |
| 200-day SMA: | 12.6 | Sell |
| 8-day EMA: | 8.86 | Buy |
| 20-day EMA: | 8.53 | Buy |
| 50-day EMA: | 8.52 | Buy |
| 200-day EMA: | 12.68 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 62.26 | Buy |
| Chaikin Money Flow: | 3972347 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.68 - 9.32) | Buy |
| Bollinger Bands (100): | (7.55 - 10.19) | Buy |
Intellia Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 9.60 while NTLA 8-day simple moving average is 8.74, which is a Buy signal.
-
The stock price of NTLA is 9.60 while Intellia Therapeutics 20-day SMA is 8.46, which makes it a Buy.
-
Intellia Therapeutics 50-day simple moving average is 8.18 while NTLA share price is 9.60, making it a Buy technically.
-
NTLA stock price is 9.60 and Intellia Therapeutics 200-day simple moving average is 12.60, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
37
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $9.60. The Score for NTLA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
994.4M
Price in USD:
9.60
Share Volume:
5.8M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
37
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 9.60 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 9.60 while NTLA 8-day exponential moving average is 8.86, which is a Buy signal.
-
The stock price of NTLA is 9.60 while Intellia Therapeutics 20-day EMA is 8.53, which makes it a Buy.
-
Intellia Therapeutics 50-day exponential moving average is 8.52 while NTLA share price is 9.60, making it a Buy technically.
-
NTLA stock price is 9.60 and Intellia Therapeutics 200-day simple moving average is 12.68, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.12 per share, and an increase next year of $0.30 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 62.26, which suggest Intellia Therapeutics is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.68 - 9.32), which suggest Intellia Therapeutics is a Buy
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.55 - 10.19), which suggest Intellia Therapeutics is a Buy
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.